U
HSTO

UBS’s Histogen Inc. Common Stock HSTO Stock Holding History

UBS’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15
Closed -$26K – 10905
2014
Q2 		$26K Buy
+15
New +$20K ﹤0.01% 7744

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

UBS's HSTO Position: Q3 2014 in Review

UBS opened a new position in Histogen Inc. Common Stock (HSTO) in Q3 2014: 12 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #8469 among its holdings.

34 funds tracked by Wall St. Rank hold HSTO as of Q3 2014.

  • UBS held 12 shares of Histogen Inc. Common Stock worth $14K as of Q3 2014.
  • Histogen Inc. Common Stock was a new UBS position in Q3 2014.
  • Histogen Inc. Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8469 holding.
  • 34 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.